Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

IMRISneuro purchased in Europe by CEA-LETI for CLINATEC Platform.

IMRIS Inc. announced the sale of IMRISneuro to CEA-LETI for CLINATEC in Grenoble, France.

Within CEA-LETI, CLINATEC is a biomedical research initiative in partnership with Grenoble University Hospital (CHU) dedicated to advancing micro nanotechnologies in support of developing therapeutic solutions for cerebral and neuro-degenerative disorders such as Parkinson’s disease and Alzheimer’s disease. CEA-LETI’s CLINATEC will become the first location in all of Europe with the unique capabilities of IMRISneuro and will use the system in conjunction with its deep brain stimulation and brain computer interface clinical studies.

The IMRISneuro suite will feature a wide bore 1.5T MRI that will move between an operating theatre and a diagnostic facility, providing state-of-the-art, multi-functional capabilities. With the IMRISneuro system within CLINATEC platform, researchers will have access to high resolution MR images on demand - before, during and after procedures without moving the patient.

Designed specifically for neurosurgery, IMRISneuro provides clinicians with timely images during procedures to assist them in making better decisions for improved patient outcomes. IMRISneuro does not require the patient to be transported for scanning, so the optimum patient positioning is never compromised. Clinical workflow and access to the patient is not impacted and the magnet is removed completely from the operating room when scanning is complete. No other system offers the same degree of safety for both the patient and the surgical environment.

Source: IMRIS

You can discuss about IMRIS and its products & services in the IMRIS Company User Group